In case you missed our symposium at the DDW Conference
Our CME webcast is available now!
AMA PRA Category 1 Credits ™
SELECT A SPEAKER TO VIEW THEIR
BIOGRAPHY AND DISCLOSURE.
Welcome and Introduction Kimberly Brown, MD, FAST, FAASLD, AGAF
Breaking News in Chronic Liver Disease Kimberly Brown, MD, FAST, FAASLD, AGAF
Clinical Case Forum I: Current and Emerging Management Approaches for the Cirrhotic Patient
Clinical Case Forum II: Current and Emerging Management Approaches
Clinical Case Forum III: Current Management Approaches for the Patient with Hepatic Encephalopathy Steven Flamm, MD, FAASLD, FACG
Expert Panel Discussion and Q&A
Back to the Agenda
KIMBERLY A. BROWN, MD, FAST, FAASLD, AGAF
Professor of Medicine, Wayne State University
Chief, Gastroenterology and Hepatology
Associate Medical Director, Henry Ford Hospital Transplant Institute
Henry Ford Hospital
Dr. Kimberly A. Brown is the chief of Gastroenterology and Hepatology at Henry Ford Hospital in Detroit. She joined the Henry Ford Medical Group in 1995 as medical director of the Liver Transplant Program and was appointed chief of the Division of Gastroenterology and Hepatology in 2003. In addition, she served as the program director for the GI Fellowship Program from 2003 to 2008. In 2016, she was appointed as the associate medical director for the Henry Ford Hospital Transplant Institute.
Dr. Brown received her undergraduate degree from the University of Michigan in 1981. She completed her medical degree at Wayne State University in 1985. Dr. Brown completed both her residency in internal medicine, as well as her fellowship in gastroenterology, at the University of Michigan in 1992 and was named chief medical resident in 1984-85.
Dr. Brown is a member of the American Gastroenterology Association, the American Association for the Study of Liver Disease, the American College of Gastroenterology, and the American Society of Transplantation. She served on the Board of Governors of the Henry Ford Medical Group for nine years, the Henry Ford Hospital and System Network Board, and was past co-chair of the Michigan Chapter of the American Liver Foundation. She was a founding board member for the ABIM Liver Transplantation and Advanced Hepatology Board. She is past treasurer and board member of the American Society of Transplantation and is involved in several committees for both the Society and hospital. She is a past member of the UNOS Liver and Intestines Committee and previously served on the executive board for the Liver and Intestines Community of Practice for the AST. She is past associate editor for the CLDF journal. Currently, Dr. Brown is the secretary for the AASLD and serves on multiple committees in that capacity.
As chief of Gastroenterology and Hepatology and past medical director of Liver Transplantation, Dr. Brown sees and manages patients with complex liver disease both before and after liver transplantation. In conjunction with Dr. Abouljoud, she worked to develop the leading liver transplant program in the State of Michigan. As fellowship director, she managed a fellowship program of 16 GI/liver fellows and continues to be involved in structuring and monitoring their education and academic success. Dr. Brown has trained over 110 fellows in advanced hepatology and transplantation. She has published over 70 articles, 110 abstracts, and eight book chapters/reviews and is a very active clinical investigator in viral hepatitis, advanced liver disease, and post liver-transplant management.
Honoraria recipient:Gilead, Pfizer, and Merck.
Research to Institution:Allergan, Conatus, Gilead, and Novartis.
Back to the Agenda
STEVEN FLAMM, MD, FAASLD, FACG
Chief of Hepatology and the Liver Transplantation Program
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Steven L. Flamm, MD is a professor of medicine and surgery with the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. He serves as the chief of transplantation hepatology and medical director of liver transplantation. Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed internal medicine training, a chief medical residency year, a clinical fellowship in gastroenterology, and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School, including a specialized year of training in liver transplantation at The Deaconess Hospital, Harvard Medical School. Dr. Flamm is a member of the American Gastroenterological Association (AGA), the American Association for the Study of Liver Diseases (AASLD), and is a fellow at the American College of Gastroenterology (ACG). He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AASLD. Currently, he is a trustee of the AASLD Foundation and chair of the AASLD Development Committee. Dr. Flamm is also currently a member of the Clinical Practice Guidelines Committee of the AGA, the Research Committee of the ACG, and the Illinois Hepatitis C State Task Force. He serves on the editorial board of Gastroenterology and Hepatology and is the chair of an AGA abstract review committee. Dr. Flamm has been the invited editor of three issues of Clinics in Liver Disease and was also the 2015 American Liver Foundation Illinois Chapter Honoree. Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many liver-related topics including viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases, including chronic viral hepatitis (HBV and HCV), hepatic encephalopathy, acute liver failure, primary biliary cholangitis, and non-alcoholic fatty liver disease (NAFLD).
Consultant: Intercept and Salix Pharmaceuticals.
Back to the Agenda
R. TODD FREDERICK, MD
San Francisco Center for Liver Disease
California Pacific Medical Center
San Francisco, California
Dr. R. Todd Frederick is a transplant hepatologist with the San Francisco Center for Liver Disease at California Pacific Medical Center. He currently serves as clinical director of Hepatology and fellowship director for Transplant Hepatology, as well as the chair of the Clinical Protocols Committee for the Division.
Dr. Frederick received his undergraduate degree in biology from the University of California, Los Angeles and his medical degree from New York Medical College in Valhalla, New York. He completed both his internal medicine residency and his fellowship in gastroenterology/hepatology at the University of California, San Diego. His clinical and research interests include the management of advanced chronic liver disease and liver failure, artificial liver support systems, hepatorenal syndrome, and portal hypertension, among other topics.
Research Support: Mallinckrodt.
Consultant:Dova, Evidera, Mallinckrodt, Morphocell, Salix Pharmaceuticals, Shionogi and Vital Therapies.
Back to the Agenda
SAMMY SAAB, MD, MPH, AGAF, FAASLD, FACG
Professor of Medicine and Surgery
Adjunct Professor of Nursing
Head, Outcomes Research in Hepatology
David Geffen School of Medicine at UCLA
Los Angeles, California
Dr. Sammy Saab is a professor in the departments of Internal Medicine and Surgery at the David Geffen School of Medicine. He is also head of outcomes research in hepatology at the Pfleger Liver Institute.
Dr. Saab received his BS, MD, and MPH degrees from UCLA. He completed his residency in internal medicine at the University of California at San Diego (UCSD) Medical Center and a fellowship in gastroenterology/hepatology at the UCLA Center for Health Sciences. He also served as chief medical resident at USCD. Dr. Saab is board certified in gastroenterology and transplant hepatology. He has received honorary fellowship from several medical societies, including the American Gastroenterology Association (AGAF), the American Association for the Study of Liver Diseases (FAASLD), and the American College of Gastroenterology (ACG).
Dr. Saab is active in many local, national, and international committees. He served on the Medical Advisory Committee of the Ventura County/ West Valley Chapter of TRIO (2005-2012), Practice Guidelines Committee of the American Society of Transplantation (2006-2008), and the Educational Committee of the American Association for the Study of Liver Diseases (2004-2007). He is currently on the local and national medical board for the American Liver Foundation.
Dr. Saab was elected to the American Association for the Study of Liver Diseases Nominating Committee in 2014. He previously served as a member of the United Network for Organ Sharing Membership and Professional Standards Committee and Performance Analysis and Improvement Subcommittee . Dr. Saab was also an active member of the Minority Affairs Committee Member and Cultural Diversity for the American College of Gastroenterology.
Dr. Saab has been an investigator in numerous clinical trials, a frequently invited speaker worldwide, and leads an annual patient education seminar.
He has been named one of the "Best Doctors in America" and has received the Distinguished Achievement Award from his Division of Digestive Diseases.
Dr. Saab has published over 300 peer-reviewed manuscripts. He has authored many book chapters, editorials, abstracts, and poster presentations.
Dr. Saab is on the editorial board of more than a dozen journals and is currently the Liver Section editor for the Journal of Clinical Gastroenterology.
Research Support: Conatus.
Speakers Bureau:AbbVie, Bayer, BMS, Dova, Eisai, Elixis, Gilead, Intercept and Salix Pharmaceuticals.
Consultant:AbbVie, Bayer, Dova, Eisai, Elixis, Gilead, Intercept, and Salix Pharmaceuticals.